Search results
Results From The WOW.Com Content Network
National Institute of Diseases of the Chest and Hospital (NIDCH) [1] [2] (Bengali: জাতীয় বক্ষব্যাধি ইনস্টিটিউট ও হাসপাতাল) is a state supported research institute and hospital in Bangladesh. [3] [4] It was established in 1955 as TB Hospital.
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Drug-resistant TB is a serious public health issue in many developing countries, as its treatment is longer and requires more expensive drugs. MDR-TB is defined as resistance to the two most effective first-line TB drugs: rifampicin and isoniazid.
After the London Fever Hospital was established in 1802, six more hospitals were established in London by the Metropolitan Asylums Board.These were designed with two separate buildings – one for smallpox patients and one for sufferers from other infectious diseases: cholera, diphtheria, dysentery, measles, scarlet fever, typhoid fever, typhus and whooping cough.
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
Present TB status of Bangladesh: According to the WHO, 'Global TB Report 2017' total population was 165 million, Bangladesh is one of the world's 30 high TB burden countries and near about 59170 people died due to tuberculosis. The total estimated number of TB patients was 364000, among them male patients were recorded at 236000, and female ...
The World Health Organization no longer endorses the concept that all those with immunologic evidence of past TB infection are currently infected and so are at risk of developing TB some time in the future. In 2022, the WHO issued corrigenda to its 2021 Global TB Report to clarify estimates on the worldwide burden of infected people. [44]
icddr,b (formerly known as the International Centre for Diarrhoeal Disease Research, Bangladesh) is an international health research organisation located in Dhaka, Bangladesh. [1] Dedicated to saving lives through research and treatment, icddr,b addresses some of the most critical health concerns facing the world today, ranging from improving ...